PURA EVERx Arnold Wrap Presentation To Include KALY Updates

Dallas, TX -- March 5, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) has scheduled an online presentation, Thursday this week, March 7^th, 2018 to review new orders, opportunities and partnerships stemming from the EVERx CBD Sports Water event this past weekend at the Arnold Sports Festival. EVERx CBD Sports Water debuted it’s all new formula and packaging at the world-renowned Arnold Sports Festival this week in Columbus, Ohio where EVERx launched for the first time ever in 2017.

The presentation will include updates on PURA’s work with Kali-Extracts (USOTC: KALY) to formulate a 25 mg CBD infused beverage. The presentation will also include highlights on new cannabis infused products the two companies are working to develop.

Analyst Speculative Buy Recommendation and $0.25 PPS Target with $0.35 Upside

Goldman Small Cap Research issued a research update on Puration, Inc. (USOTC: PURA) yesterday recommending a 'speculative-buy' rating with a target price-per-share of $0.25, with noted potential upside to the $0.35 mark.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350